NCPA testified in support of two bills, Senate Bill 372 and Senate Bill 678, in coordination with the Maryland Pharmacists Association in their efforts to expand vaccination authority for pharmacists and reimburse pharmacists within their scope of practice. SB 372 will keep authority in place as permissions granted under the PREP Act declaration for the COVID-19 pandemic expire in 2024. SB 678 requires public and private plans to provide coverage for services rendered within a pharmacist’s scope of practice and that reimbursement not be conditioned on whether the pharmacist is employed by a physician, pharmacy or facility, or is acting under a physician’s order.
NCPA
